Avant Genomics
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$3M
Momentum Score
25 /100
Company Overview
Avant Genomics is a biotechnology company developing a first-of-its-kind platform that automates liquid biopsy sample preparation for blood-based cancer detection.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Precision Medicine, Medical Devices, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avant Genomics Comps
Public and private peers based on sector, stage, and business model.
Avant Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 |
Key People
Founding team and executive leadership
Avant Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Impact Fund | Seed |
| CAV Angels | Seed |
| Halyard Ventures | Seed |
| Virginia Venture Partners | Seed |
| TitletownTech | Seed |
| Virginia Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$3M round led by TitletownTech
Avant Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avant Genomics's valuation, stock price, and market status.
